Sai Life Sciences Expands API Manufacturing in Bidar with Completion of PB-11 Phase II – The Indian Awaaz

Sai Life Sciences Completes Phase II Expansion of PB-11 Production Block, Increasing Reactor Capacity to 700 KL

Sai Life Sciences has completed the Phase II expansion […] The post Sai Life Sciences Completes Phase II Expansion of PB-11 Production Block, Increasing Reactor Capacity to 700 KL first appeared on GeneOnline News. The post Sai Life Sciences Completes Phase II Expansion of PB-11 Production Block, Increasing Reactor Capacity to 700 KL appeared first on GeneOnline News.

Sai Life Sciences Expands API Manufacturing in Bidar with Completion of PB-11 Phase II – The Indian Awaaz

BIZ DESK Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), a leading Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the successful completion of Phase II of its new Production Block (PB-11) at its flagship API manufacturing facility in Bidar, Karnataka. Phase I of PB-11, inaugurated in December 2024, added 110 KL of […]